DBV TECHNOLOGIES Aktie

1,56 EUR +0,01 EUR +0,65 %

26.09.2025

BMN

1,54 EUR ±0,00 EUR +0,26 %

26.09.2025

PAR

DBV TECHNOLOGIES jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.210,62 Mio. EUR

Div. Rendite0,00%

WKNA1JWB7

ISINFR0010417345

SymbolDBVTF

DBV TECHNOLOGIES Aktien News

Sortieren:Datum Meistgelesen

31.07.25finanzen.netDBV TECHNOLOGIES: Bilanz zum abgelaufenen Quartal

12.06.25GlobeNewswireDBV Technologies to Participate in Upcoming EAACI Congress 2025

11.06.25GlobeNewswireDBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

WerbungDBV TECHNOLOGIES-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

04.06.25GlobeNewswireInformation Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025

03.06.25GlobeNewswireDBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

21.05.25ZacksAre Medical Stocks Lagging DBV Technologies (DBVT) This Year?

16.05.25ZacksAre You Looking for a Top Momentum Pick? Why DBV Technologies S.A. (DBVT) is a Great Choice

16.05.25ZacksDBV Technologies (DBVT) Is a Great Choice for 'Trend' Investors, Here's Why

15.05.25GlobeNewswireCombined General Meeting of June 11, 2025

06.05.25GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025

05.05.25GlobeNewswireDBV Technologies to Participate in the Citizens JMP Life Sciences Conference

30.04.25GlobeNewswireDBV Technologies Reports First Quarter 2025 Financial Results

30.04.25ZacksHere's Why Momentum in DBV Technologies (DBVT) Should Keep going

14.04.25ZacksHere's What Could Help DBV Technologies (DBVT) Maintain Its Recent Price Strength

11.04.25GlobeNewswireDBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document

28.03.25BenzingaWhy DBV Technologies (DBVT) Stock Is Skyrocketing

28.03.25GlobeNewswireDBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved

25.03.25finanzen.netDBV TECHNOLOGIES gab Ergebnis zum abgelaufenen Quartal bekannt

24.03.25GlobeNewswireDBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Rep

25.02.25GlobeNewswireDBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress

13.01.25GlobeNewswireHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

08.01.25GlobeNewswireDBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study

12.12.24BenzingaWhy DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

11.12.24GlobeNewswireDBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old

02.12.24GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024

11.11.24GlobeNewswireDBV Technologies Announces Plan to Implement ADS Ratio Change

08.11.24finanzen.netDBV TECHNOLOGIES: Bilanzvorlage zum letzten Quartal

06.11.24GlobeNewswireDBV Technologies Reports Third Quarter 2024 Financial Results

23.10.24BenzingaPenny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway

22.10.24GlobeNewswireDBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe

18.10.24GlobeNewswireDBV Technologies to Participate in Upcoming ACAAI 2024 Congress

14.10.24GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024

23.09.24GlobeNewswireDBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial

04.09.24GlobeNewswireDBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

02.08.24GlobeNewswireInformation regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024

01.08.24finanzen.netDBV TECHNOLOGIES präsentierte das Zahlenwerk zum abgelaufenen Jahresviertel

30.07.24GlobeNewswireDBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results

29.07.24GlobeNewswireDBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024

08.07.24GlobeNewswireHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

05.06.24GlobeNewswireDBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

DBV TECHNOLOGIES News

DBV TECHNOLOGIES News: auf dieser Seite finden Sie alle DBV TECHNOLOGIES News und Nachrichten zur DBV TECHNOLOGIES Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch DBV TECHNOLOGIES News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um DBV TECHNOLOGIES News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.